Medical Disclaimer: This article is for educational purposes only. Supplements are not FDA-regulated medications and are not substitutes for evidence-based psychiatric treatment. Always discuss supplements with your prescriber before starting — interactions with psychiatric medications can occur.

Why Supplements Come Up in Psychiatry

More patients ask about supplements than ever before — for mood, focus, sleep, and anxiety. The honest answer: some have meaningful evidence behind them, others have very little, and almost none should replace established treatments. What they can do, in the right context, is complement standard care. Here is an evidence-informed look at the most commonly discussed supplements in psychiatric practice.

Supplements at a Glance

Omega-3 Fatty Acids (EPA & DHA) — Strong Evidence

EPA-predominant formulations (≥60% EPA, 1–2 g/day) have shown consistent benefit as adjuncts to antidepressants across multiple meta-analyses. Preliminary evidence also supports benefits in bipolar depression and ADHD. Fish oil is the most common form; algal oil provides DHA but less EPA. GI side effects are the main complaint.

Best studied for: Depression (adjunct), ADHD

Vitamin D — Moderate Evidence

Vitamin D receptors are found throughout the brain, and deficiency is extremely common — particularly in northern latitudes, older adults, and people with darker skin. Correcting a documented deficiency often improves energy and mood. Evidence for benefit in non-deficient individuals is mixed. Check a 25-OH vitamin D level; supplement with D3 if below 30 ng/mL (typical dose: 1,000–5,000 IU/day).

Best studied for: SAD, deficiency-related mood changes

Magnesium — Moderate Evidence

Magnesium is involved in over 300 enzymatic reactions including NMDA receptor regulation, cortisol modulation, and serotonin synthesis. Low levels are associated with anxiety, depression, and poor sleep. A 2017 RCT found significant improvement in depression and anxiety with magnesium chloride supplementation. Glycinate and threonate are better-tolerated forms. Typical dose: 200–400 mg elemental magnesium daily.

Best studied for: Anxiety, depression (adjunct), sleep

Probiotics & the Gut–Brain Axis — Emerging Evidence

Approximately 90% of serotonin is produced in the gut, and the gut microbiome communicates directly with the brain via the vagus nerve. Several RCTs suggest multi-strain probiotics may reduce anxiety and depressive symptoms. This is one of the most actively researched areas in psychiatry. Results are promising but not yet sufficient to recommend as a primary treatment.

Best studied for: Anxiety reduction, IBS-related mood symptoms

L-Methylfolate — Strong Evidence

L-methylfolate is the bioavailable form of folate that crosses the blood-brain barrier. It is involved in neurotransmitter synthesis (serotonin, dopamine, norepinephrine). In patients with the MTHFR gene variant who metabolize folate poorly, standard antidepressants may underperform. L-methylfolate (7.5–15 mg/day) is FDA-cleared as a medical food adjunct for depression. This is one of the most clinically useful nutraceuticals in psychiatry.

Best studied for: Treatment-resistant depression (adjunct)

NAC (N-Acetylcysteine) — Moderate Evidence

NAC is a precursor to glutathione, the brain’s primary antioxidant. It modulates glutamate and dopamine systems implicated in OCD, addiction, and bipolar disorder. RCTs have shown benefit for OCD compulsions, cannabis use disorder, and bipolar depression. Typical dose: 1,200–2,400 mg/day. Generally well-tolerated; GI upset is the main side effect.

Best studied for: OCD (adjunct), addiction, bipolar depression